Additionally, our findings highlight the potential of HDAC9 inhibition as a therapeutic intervention to potentially prevent progression of large artery stroke, and provide a cellular human hiPSC-derived disease model with easy phenotypic readout for high-throughput screening of such inhibitors. Here, HDAC9 is linked to large artery stroke.